Skip Navigation

European Heart Journal 2002 23(10):764-766; doi:10.1053/euhj.2001.3056
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kaye, D.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaye, D.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Alterations in oxygen consumption and sympathetic nervous activity in heart failure: independent or associated mechanisms?

D.M. Kaye

Baker Medical Research Institute, Melbourne, Australia

References

  1. Cohn J, Levine T, Olivari M. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819–823[Abstract]
  2. Kaye DM, Lefkovits J, Jennings G. Adverse consequences of increased cardiac sympathetic activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257–1263[Abstract]
  3. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355[Abstract/Free Full Text]
  4. Lancet. 1999;353:9–13[CrossRef][Web of Science][Medline]
  5. Lancet. 1999;353:2001–2007[CrossRef][Web of Science][Medline]
  6. N Engl J Med. 1991;325:293–302[Abstract]
  7. Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–717[Abstract/Free Full Text]
  8. Aaronson KD, Schwartz JS, Chen TM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–2667[Abstract/Free Full Text]
  9. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation. 1997;95:169–175[Abstract/Free Full Text]
  10. Kaye DM, Lambert GW, Lefkovits J. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570–578[Abstract]
  11. Kaye DM, Jennings GL, Dart AM. Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. J Am Coll Cardiol. 1998;a31:583–587
  12. Azevedo ER, Newton GE, Floras JS. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. Circulation. 2000;101:2053–2059[Abstract/Free Full Text]
  13. Narkiewicz K, Pesek CA, van de Borne PJ. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation. 1999;100:262–267[Abstract/Free Full Text]
  14. Andersen P, Saltin B. Maximal perfusion of skeletal muscle in man. J Physiol. 1985;366:233–249[Abstract/Free Full Text]
  15. Sullivan MJ, Knight JD, Higginbotham MB. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989;80:769–781[Abstract/Free Full Text]
  16. Florea VG, Mareyev VY, Achilov AA. Central and peripheral components of chronic heart failure: determinants of exercise tolerance. Int J Cardiol. 1999;70:51–56[CrossRef][Web of Science][Medline]
  17. Joyner MJ, Nauss LA, Warner MA. Sympathetic modulation of blood flow and O2 uptake in rhythmically contracting human forearm muscles. Am J Physiol. 1992;263:H1078–1083
  18. Kardos A, Taylor DJ, Thompson C. Sympathetic denervation of the upper limb improves forearm exercise performance and skeletal muscle bioenergetics. Circulation. 2000;101:2716–2720[Abstract/Free Full Text]
  19. Lang CC, Rayos GH, Chomsky DB. Effect of sympathoinhibition on exercise performance in patients with heart failure. Circulation. 1997;96:238–245[Abstract/Free Full Text]
  20. Silber DH, Sutliff G, Yang QX. Altered mechanisms of sympathetic activation during rhythmic forearm exercise in heart failure. J Appl Physiol. 1998;84:1551–1559[Abstract/Free Full Text]
  21. Notarius CF, Azevedo ER, Parker JD, Floras JS. Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure. Eur Heart J. 2002;23:800–805[Abstract/Free Full Text]
  22. Kaye DM, Lefkovits J, Cox H. Regional epinephrine kinetics in human heart failure: evidence for extra-adrenal, nonneural release. Am J Physiol. 1995;269:H182–188
  23. Rundqvist B, Eisenhofer G, Elam M. Attenuated cardiac sympathetic responsiveness during dynamic exercise in patients with heart failure. Circulation. 1997;95:940–945[Abstract/Free Full Text]
  24. Brunner-LaRocca HP, Esler MD, Jennings GL. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J. 2002;:
  25. Kaye DM, Johnston L, Vaddadi G. Mechanisms of carvedilol action in human congestive heart failure. Hypertension. 2001;37:1216–1221[Abstract/Free Full Text]
  26. Guazzi M, Agostoni P, Matturri M. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol. Am Heart J. 1999;138:460–467[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kaye, D.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaye, D.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?